Analysis of the economic operation of the national and Shanghai Chinese medicine manufacturing industry from January to November 2009
Release time: 2010-04-21 & nbsp & nbsp & nbsp Source:
stake sports betting app
January to November 2009，There are 1480 Chinese medicine manufacturing enterprises in the country，The number of enterprises ranked first in the 8 sub -industries in the pharmaceutical industry。Cumulative assets totaled 216.803 billion yuan，Total 23.12%of the assets of the industry，ranked 2nd place，After the chemical drug preparations，increased by 12.48%year -on -year。
China Pharmaceutical Manufacturing Assets Total 63.09%is a joint -stock economy type，increased by 11.63%year -on -year。Foreign capital and Hong Kong, Macao and Taiwan investment economy types followed immediately，accounting for 16.91%，increased by 13.87%year -on -year。The proportion of the state -owned economy My stake betting appand stake sports betting appcollective economy is very small，The state -owned economy accounts for 4.31%，increased by 9.91%year -on -year; negative growth in the collective economy type，decreased by 3.97%year -on -year，0.93%。
In terms of enterprise scale，Most of the small enterprises，But the concentration of corporate assets is relatively high。From January to November 2009, there are 24 large companies in the Chinese Pharmaceutical Manufacturing Industry，Cumulative assets account for 26.54%，increased by 16.06%year -on -year。221 medium -sized enterprises，Cumulative realization of assets account for 37.46%，increased by 12.60%year -on -year。There are 1235 small enterprises，Cumulative realization of the total assets accounting for 36%of the Chinese medicine industry，increased by 9.87%year -on -year。
From January to November 2009, Shanghai Chinese Pharmaceutical Manufacturing Industry，Cumulative realization of assets totaling 3.944 billion yuan，1.82%，Row 20 in the country，increased by 3.92%year -on -year。Shanghai's adult medicine manufacturing industry ranks 5th among the eight major industries in Shanghai，Total 7.94%of the assets in Shanghai's pharmaceutical industry。
Shanghai Zhongda Pharmaceutical Manufacturing Co., Ltd.，increased by 2.34%year -on -year。Foreign investment economy, Hong Kong, Macao and Taiwan investment economy，accounting for 14.57%，increased by 3.78%year -on -year。State -owned economy、The collective economy accounts for 0.71%、0.15%，decline year -on -year，was -12.06%、-6.46%。
From January to November 2009, there are 25 companies in Shanghai's patent medicine manufacturing industry，Among them, there are 1 large enterprise，Cumulative assets account for 38.22%，Asset concentration is high，but a decrease of 6.19%year -on -year。medium -sized enterprises account for 26.50%，increased by 27.55%year -on -year。Small enterprises account for 35.28%，increased by 1.66%year -on -year。
2 Analysis of production conditions
From January to November 2009, the cumulative industrial output value of the Chinese Pharmaceutical Manufacturing Industry was 187.147 billion yuan，Occupy the total industrial output value of the industry 21.08%，Rank No. 2，After the chemical drug preparation industry，year -on -year increase of 22.38%。
Shanghai's patent medicine manufacturing industry has completed the total industrial output value of 2.656 billion yuan，Ranking 22nd bit，increased by 7.42%year -on -year。Shanghai's patent medicine manufacturing industry accounts for 6.87%of the total industrial output value of Shanghai pharmaceutical industry，ranked 5th among the 8 sub -industries。
National Chinese Pharmaceutical Manufacturing Industry Cumulative Economic Types cumulative 57.66%of the total industrial output value，increased by 22.92%year -on -year; followed by other economic types。Foreign capital and Hong Kong, Macao and Taiwan investment economy ranked 3rd，accounting for 16.6%，increased by 19.19%year -on -year。The proportion of the state -owned economy My stake betting appand stake sports betting appcollective economy is small，The sum of no more than 5%。
National Chinese Pharmaceutical Manufacturing Industry Small Enterprises achieved a total of 42.88%of the total industrial output value of the Chinese medicine industry，increased by 29.20%year -on -year，But the total industrial output value of large enterprises accounts for 23.29%，Near 1/3，The concentration of large -scale enterprises in Chinese patent medicine is still obvious，Its year -on -year increase of 22.01%。Middle -size enterprises have achieved a total of total industrial output value accounting for 33.83%，increased by 14.94%year -on -year。
The structure of the Chinese medicine industry in Shanghai is the same as the whole country，The cumulative industrial output value of the shareholding economy accounts for 70.82%，The advantage is more obvious，increased by 1.34%year -on -year。Foreign investment economy in foreign investment, Hong Kong, Macao and Taiwan, the total industrial output value accounts for 21.72%，increased by 26.36%year -on -year。State -owned economy accounts for 1.11%。decreased by 10.89%year -on -year，collective economy accounts for 0.32%，increased by 7.72%year -on -year。
Shanghai Chinese Pharmaceutical Manufacturing Enterprise Cumulative A total of total industrial output value and similar nationwide，The production concentration of large enterprises is more obvious。Small enterprises have achieved cumulative industrial output value accounting for 40.15%，increased by 5.38%year -on -year。Middle -sized enterprises account for 35.69%，increased by 28.39%year -on -year。Large enterprises account for 24.17%，decreased 11.15%year -on -year。
3 sales analysis
3.1 sales value
From January to November 2009, the cumulative industrial sales output value of the national Chinese medicine manufacturing industry was 176.695 billion yuan，Occupy the industrial sales output value of the pharmaceutical industry 20.88%，Ranking 2nd in the eight major industries，increased by 22.33%year -on -year。From January to November 2009，decreased by 0.05 percentage points year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total of 2.610 billion yuan in industrial sales，Occupy the industrial sales output value of Shanghai pharmaceutical industry 6.95%，5th in the eight major sub -industries in Shanghai's pharmaceutical industry，increased by 4.56%year -on -year。Shanghai's patent medicine manufacturing industry has achieved a total of industrial sales output values in the national patent pharmaceutical manufacturing area ranked 22nd。Shanghai's pads of medicine manufacturing from January to November 2009 was 98.28%，A year -on -year decrease of 2.68 percentage point。
From January to November 2009, the cumulative industrial sales output value of the national pharmaceutical manufacturing industry's stock system accounted for 57.54%，increased by 21.89%year -on -year，The production and sales rate is 94.22%。Followed by other economic types。Foreign capital, Hong Kong, Macao and Taiwan's investment economy, the cumulative industrial sales output value accounts for 16.6%，increased by 21.74%year -on -year，The production and sales rate is 94.40%。
From January to November 2009, the cumulative realization of industrial sales output values accounted for 23.70%，increased by 21.79%year -on -year，The production and sales rate is 96.06%。medium -sized enterprises account for 33.45%，increased by 14.93%year -on -year，The production and sales rate is 93.36%。Small enterprises account for 42.85%，increased by 29.12%year -on -year，The production and sales rate is 94.36%。Similar sales structure and output value of enterprises in various scale。
From January to November 2009, Shanghai Sinopastic Pharmaceutical Manufacturing Economy has accumulated industrial sales output value accounted for 72.17%of Shanghai's Chinese medicine industry 72.17%，decreased by 1.58%year -on -year，The production and sales rate is 100.16%。Foreign investment and Hong Kong, Macao and Taiwan investment account for 20.86%，increased by 25.31%year -on -year，The production and sales rate is 94.42%。State -owned economy accounts for 1.15%，decreased by 7.99%year -on -year，The production and sales rate is 101.96%。
Shanghai's major enterprises in China Pharmaceutical Manufacturing Industry Cumulative industrial sales output value accounts for 26.65%in Shanghai Zhongda Pharmaceutical Industry，decreased by 7.42%year -on -year，The production and sales rate is 108.39%。medium -sized enterprises account for 34.13%，increased by 18.09%year -on -year，The production and sales rate is 93.99%。Small enterprises account for 39.22%，increased by 3.35%year -on -year，The production and sales rate is 96.01%。
3.2 Main business income
From January to November 2009, the cumulative main business revenue of the National Pharmaceutical Manufacturing Industry was 169.896 billion yuan，Occupy the main business income of the pharmaceutical industry 20.18%，ranked 3rd among the eight major sub -industries，increased by 22.89%year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total of 4.086 billion yuan in main business income，occupying the main business income of Shanghai pharmaceutical industry 10.28%，5th in the eight major sub -industries in Shanghai's pharmaceutical industry，increased by 3.95%year -on -year。Shanghai's patent medicine manufacturing industry has achieved a total of main business My stake betting appStake Sports Bettingincome in the nation's patent pharmaceutical manufacturing region (19th place。
From January to November 2009, the cumulative market revenue of the national proprietary pharmaceutical manufacturing industry has accumulated main business income accounted for 58.57%，increased by 22.86%year -on -year。Followed by other economic types。Foreign capital, Hong Kong, Macao and Taiwan's investment economy cumulative main business income accounted for 15.88%，increased by 21.99%year -on -year。The state -owned economy accounts for 4.24%，increased by 6.75%year -on -year。The collective economy decreased by 5.71%year -on -year。
From January to November 2009, the large-scale enterprises in the country's Chinese medicine manufacturing industry have achieved the main business income account for 26.96%，increased by 21.57%year -on -year。medium -sized enterprises account for 32.23%，increased by 12.21%year -on -year。Small enterprises account for 40.81%，increased by 33.93%year -on -year。
From January to November 2009, Shanghai's proprietary Chinese medicine manufacturing industry stock system has achieved the main business income accounted for 82.28%of Shanghai's Chinese medicine industry 82.28%，increased by 0.18%year -on -year。Foreign investment and Hong Kong, Macao and Taiwan investment accounted for 13.56%，increased by 26.50%year -on -year。State -owned economy accounts for 0.66%，decreased by 10.10%year -on -year。
Shanghai's major enterprises in China Pharmaceutical Manufacturing Industry Cumulative Realization of the main business income accounted for 46.48%in Shanghai Zhongcheng Pharmaceutical Industry，decreased by 12.06%year -on -year。Middle -sized enterprises account for 23.19%，increased by 24.17%year -on -year。Small enterprises account for 30.33%，year -on -year increase of 22.93%。
3.3 Export delivery value
From January to November 2009, the cumulative export delivery value of the Chinese Pharmaceutical Manufacturing Industry National Pharmaceutical Manufacturing Industry was 4.144 billion yuan，accounting for 4.53%，ranked 6th among the eight major sub -industries in the pharmaceutical industry，increased by 15.75%year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total export delivery value of 214 million yuan，Occupable export value of Shanghai pharmaceutical industry 3.67%，No. 6 among the eight major sub -industries in Shanghai's pharmaceutical industry，increased by 1.69%year -on -year。Shanghai's patent medicine manufacturing industry from January to November 2009, the cumulative export delivery value ranked 6th in all regions of the country。
From January to November 2009, the cumulative export delivery value of the National Pharmaceutical Manufacturing Industry and the Hong Kong, Macao and Taiwan investment economy accounted for 47.85%，increased by 66.24%year -on -year。Second, the joint -stock economy accounts for 37.76%，decreased by 8.19%year -on -year。State -owned economy accounts for 10.74%，increased by 42.67%year -on -year。Other economic types decreased by 64.26%year -on -year。
From January to November 2009, the cumulative export delivery value of large-scale enterprises in China Pharmaceutical Manufacturing Industry accounted for 12.20%，increased by 6.54%year -on -year。Middle -sized enterprises account for 53.04%，increased by 11.29%year -on -year。Small enterprises account for 34.76%，increased by 27.40%year -on -year。
Shanghai's patent medicine manufacturing industry and Hong Kong, Macao and Taiwan investment economy cumulative export delivery value accounts for 89.63%of Shanghai's Chinese medicine industry 89.63%，increased by 9.62%year -on -year。The shareholding economy accounts for 10.37%，decreased by 37.44%year -on -year。State -owned economy、The collective economy and other economic types have no export delivery value。
From January to November 2009, large enterprises in Shanghai Zhongda Pharmaceutical Manufacturing Industry Cumulative export delivery value accounted for 3.69%of Shanghai Zhongda Pharmaceutical Industry，decreased by 12.35%year -on -year。Middle -sized enterprises account for 6.68%，decreased by 45.35%year -on -year。Small enterprises account for 89.63%，increased by 9.43%year -on -year。
4 Analysis of profit and profitability
4.1 Total profit
From January to November 2009, the cumulative total profit of the National Pharmaceutical Manufacturing Industry National Pharmaceutical Manufacturing Industry was 18.101 billion yuan，accounting for 20.94% in the national pharmaceutical industry，ranked 2nd among the eight major sub -industries in the pharmaceutical industry，increased by 25.44%year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total profit of 205 million yuan，accounting for the total profit of Shanghai's pharmaceutical industry 4.16%，5th in the eight major sub -industries in Shanghai's pharmaceutical industry，decreased by 1.91%year -on -year。Shanghai's patent medicine manufacturing industry ranked 20th in all regions of the country's Chinese medicine industry。
From January to November 2009, the cumulative profit of the national pharmaceutical manufacturing industry's stock system has accumulated total profit accounted for 59.71%，increased by 23.77%year -on -year。Foreign investment economy with foreign investment and Hong Kong, Macao and Taiwan accounted for 21.73%，increased by 21.68%year -on -year。The state -owned economy accounts for 4.01%，increased by 72.86%year -on -year。The collective economy decreased by 46.87%year -on -year。
From January to November 2009, the cumulative total profit of large-scale enterprises in China Pharmaceutical Manufacturing Industry accounted for 33.12%，increased by 17.93%year -on -year。Middle -sized enterprises account for 38.94%，increased by 20.03%year -on -year。Small enterprises account for 27.95%，increased by 45.57%year -on -year。
From January to November 2009, the cumulative profit of the shareholding economy in Shanghai China Pharmaceutical Manufacturing Industry has accumulated total My stake betting appprofits accounting for 68%，decreased by 13.96%year -on -year。stake betting appalso caused the overall decline in Shanghai's patent medicine manufacturing industry as a whole。Foreign investment economy in foreign investment, Hong Kong, Macao and Taiwan, a total of 29.35%，increased by 41.03%year -on -year。A total of the total profit of the state -owned economy loses a loss，Loss of 31 million yuan。
Local losses of large enterprises in Shanghai's pads medicine manufacturing industry，Loss of RMB 110 million，decreased by 123.90%year -on -year。directly affects the overall profit of Shanghai Zhongcheng Pharmaceutical Industry，Caused a decrease year -on -year。Middle -sized enterprises have achieved cumulative My stake betting appprofits accounting for 65.86%，increased by 46.83%year -on -year。Small enterprises account for 39.36%，increased by 11.75%year -on -year。
4.2 Cost cost profit margin
From January to November 2009, the cost and profit margin of the national pharmaceutical manufacturing industry is 12.04%，increased by 0.25 percentage points year -on -year。ranked 4th among the eight major sub -industries in the pharmaceutical industry。
The cost of profit margin in Shanghai's patent medicine manufacturing industry is 5.25%，No. 6 among the eight major sub -industries in Shanghai's pharmaceutical industry，decreased by 0.33 percentage points year -on -year。The cost rate of the cost and cost of Shanghai's patent medicine manufacturing industry is ranked 25th in the country's Chinese medicine industry area。
From January to November 2009, the cost rate of foreign investment in Chinese medicine manufacturing and Hong Kong, Macao and Taiwan investment economy is 17.17%，decreased by 0.04 percentage point year -on -year。Followed by the joint -stock economy，Cost cost profit margin is 12.18%，increased by 0.03 percentage points year -on -year。State -owned economic cost and cost profit margin is 11.18%，increased by 4.43 percentage points year -on -year。
From January to November 2009, the cost of large-scale enterprises in the national patent medicine manufacturing industry is 14.69%，decreased by 0.50 percentage point year -on -year。Middle -size enterprise cost and cost profit margin is 14.93%，increased by 0.96 percentage points year -on -year。Small enterprises are 8.11%，increased by 0.70 percentage points year -on -year。
The cost cost of the state -owned economy investment in the Chinese patent medicine manufacturing industry in Shanghai，The result obtained is the total profit of the total profit of the cumulative profit of January to November 2009。Foreign capital, Hong Kong, Macao and Taiwan's investment economy cost and expenditure profit margin is 12.17%，increased by 1.40 percentage points year -on -year。The shareholding economy is 4.30%，decreased by 0.75 percentage point year -on -year。
The cost cost of large -scale enterprises in Shanghai's major enterprises in China Pharmaceutical Manufacturing Industry，The result obtained was the total loss of total profit in January to November 2009。Middle -size enterprise cost and cost profit margin is 16.65%，increased by 2.87 percentage points year -on -year。Small enterprises are 6.97%，decreased by 0.73 percentage points year -on -year。
5 Summary
my country's Chinese Pharmaceutical Manufacturing Industry continues to maintain a good growth momentum from January to November 2009，Enterprises continue to increase，Leap the first place，This has advocated the development of Chinese medicine in recent years，There is a lot of connection to promoting the modernization of Chinese medicine。China Pharmaceutical Manufacturing Industry is still maintained in the three major pillar industries in my country's pharmaceutical industry。January to November 2009，Chinese adults are in production、Sales、profit and other indicators exceeded the original medicine industry of chemical drugs。But in terms of export，China Pharmaceutical Manufacturing Industry needs to take a long way，The development of Chinese medicine abroad can be said to be very successful，How to improve the exit of Chinese medicine，It will be the direction of the efforts of my country's Chinese medicine companies in the future。For Shanghai for the forefront of reform and opening up in my country，Cities that have attracted much attention from the foreign investment community，The development of Chinese patent medicine is not enough，Among the 8 sub -industries in Shanghai's pharmaceutical industry，The indicators of the Chinese medicine industry are arranged behind，Shanghai Chinese Yaoshi is even more backward in the country。Chinese medicine is the treasure of the Chinese nation，To develop modernization of Chinese medicine，Chinese medicine goes abroad，Shanghai has geographical advantages and international influence，If you have good policy support，Shanghai's proprietary patent medicine will be used later。
Shanghai Zhongda Pharmaceutical Industry is similar in terms of scale and economic structure，The size of the enterprise is still mainly small enterprises，But large enterprises are producing、Sales、profit rates such as profit and other indicators are high。Exit，Large enterprises are not as good as medium My stake betting app-sized enterprises and Stake Sports Bettingsmall enterprises。The investment in foreign investment in my country ’s medicine industry is growing，Chinese medicine companies invested in foreign investment and Hong Kong, Macao and Taiwan pay more attention to the export of Chinese patent medicines，From January to November 2009, the cumulative export delivery value was the most。Zhongcheng Pharmaceutical Enterprise is still mainly based on a joint -stock economy。
January to November 2009，There are 1480 Chinese medicine manufacturing enterprises in the country，The number of enterprises ranked first in the 8 sub -industries in the pharmaceutical industry。Cumulative assets totaled 216.803 billion yuan，Total 23.12%of the assets of the industry，ranked 2nd place，After the chemical drug preparations，increased by 12.48%year -on -year。
China Pharmaceutical Manufacturing Assets Total 63.09%is a joint -stock economy type，increased by 11.63%year -on -year。Foreign capital and Hong Kong, Macao and Taiwan investment economy types followed immediately，accounting for 16.91%，increased by 13.87%year -on -year。The proportion of the state -owned economy My stake betting appand stake sports betting appcollective economy is very small，The state -owned economy accounts for 4.31%，increased by 9.91%year -on -year; negative growth in the collective economy type，decreased by 3.97%year -on -year，0.93%。
In terms of enterprise scale，Most of the small enterprises，But the concentration of corporate assets is relatively high。From January to November 2009, there are 24 large companies in the Chinese Pharmaceutical Manufacturing Industry，Cumulative assets account for 26.54%，increased by 16.06%year -on -year。221 medium -sized enterprises，Cumulative realization of assets account for 37.46%，increased by 12.60%year -on -year。There are 1235 small enterprises，Cumulative realization of the total assets accounting for 36%of the Chinese medicine industry，increased by 9.87%year -on -year。
From January to November 2009, Shanghai Chinese Pharmaceutical Manufacturing Industry，Cumulative realization of assets totaling 3.944 billion yuan，1.82%，Row 20 in the country，increased by 3.92%year -on -year。Shanghai's adult medicine manufacturing industry ranks 5th among the eight major industries in Shanghai，Total 7.94%of the assets in Shanghai's pharmaceutical industry。
Shanghai Zhongda Pharmaceutical Manufacturing Co., Ltd.，increased by 2.34%year -on -year。Foreign investment economy, Hong Kong, Macao and Taiwan investment economy，accounting for 14.57%，increased by 3.78%year -on -year。State -owned economy、The collective economy accounts for 0.71%、0.15%，decline year -on -year，was -12.06%、-6.46%。
From January to November 2009, there are 25 companies in Shanghai's patent medicine manufacturing industry，Among them, there are 1 large enterprise，Cumulative assets account for 38.22%，Asset concentration is high，but a decrease of 6.19%year -on -year。medium -sized enterprises account for 26.50%，increased by 27.55%year -on -year。Small enterprises account for 35.28%，increased by 1.66%year -on -year。
2 Analysis of production conditions
From January to November 2009, the cumulative industrial output value of the Chinese Pharmaceutical Manufacturing Industry was 187.147 billion yuan，Occupy the total industrial output value of the industry 21.08%，Rank No. 2，After the chemical drug preparation industry，year -on -year increase of 22.38%。
Shanghai's patent medicine manufacturing industry has completed the total industrial output value of 2.656 billion yuan，Ranking 22nd bit，increased by 7.42%year -on -year。Shanghai's patent medicine manufacturing industry accounts for 6.87%of the total industrial output value of Shanghai pharmaceutical industry，ranked 5th among the 8 sub -industries。
National Chinese Pharmaceutical Manufacturing Industry Cumulative Economic Types cumulative 57.66%of the total industrial output value，increased by 22.92%year -on -year; followed by other economic types。Foreign capital and Hong Kong, Macao and Taiwan investment economy ranked 3rd，accounting for 16.6%，increased by 19.19%year -on -year。The proportion of the state -owned economy My stake betting appand stake sports betting appcollective economy is small，The sum of no more than 5%。
National Chinese Pharmaceutical Manufacturing Industry Small Enterprises achieved a total of 42.88%of the total industrial output value of the Chinese medicine industry，increased by 29.20%year -on -year，But the total industrial output value of large enterprises accounts for 23.29%，Near 1/3，The concentration of large -scale enterprises in Chinese patent medicine is still obvious，Its year -on -year increase of 22.01%。Middle -size enterprises have achieved a total of total industrial output value accounting for 33.83%，increased by 14.94%year -on -year。
The structure of the Chinese medicine industry in Shanghai is the same as the whole country，The cumulative industrial output value of the shareholding economy accounts for 70.82%，The advantage is more obvious，increased by 1.34%year -on -year。Foreign investment economy in foreign investment, Hong Kong, Macao and Taiwan, the total industrial output value accounts for 21.72%，increased by 26.36%year -on -year。State -owned economy accounts for 1.11%。decreased by 10.89%year -on -year，collective economy accounts for 0.32%，increased by 7.72%year -on -year。
Shanghai Chinese Pharmaceutical Manufacturing Enterprise Cumulative A total of total industrial output value and similar nationwide，The production concentration of large enterprises is more obvious。Small enterprises have achieved cumulative industrial output value accounting for 40.15%，increased by 5.38%year -on -year。Middle -sized enterprises account for 35.69%，increased by 28.39%year -on -year。Large enterprises account for 24.17%，decreased 11.15%year -on -year。
3 sales analysis
3.1 sales value
From January to November 2009, the cumulative industrial sales output value of the national Chinese medicine manufacturing industry was 176.695 billion yuan，Occupy the industrial sales output value of the pharmaceutical industry 20.88%，Ranking 2nd in the eight major industries，increased by 22.33%year -on -year。From January to November 2009，decreased by 0.05 percentage points year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total of 2.610 billion yuan in industrial sales，Occupy the industrial sales output value of Shanghai pharmaceutical industry 6.95%，5th in the eight major sub -industries in Shanghai's pharmaceutical industry，increased by 4.56%year -on -year。Shanghai's patent medicine manufacturing industry has achieved a total of industrial sales output values in the national patent pharmaceutical manufacturing area ranked 22nd。Shanghai's pads of medicine manufacturing from January to November 2009 was 98.28%，A year -on -year decrease of 2.68 percentage point。
From January to November 2009, the cumulative industrial sales output value of the national pharmaceutical manufacturing industry's stock system accounted for 57.54%，increased by 21.89%year -on -year，The production and sales rate is 94.22%。Followed by other economic types。Foreign capital, Hong Kong, Macao and Taiwan's investment economy, the cumulative industrial sales output value accounts for 16.6%，increased by 21.74%year -on -year，The production and sales rate is 94.40%。
From January to November 2009, the cumulative realization of industrial sales output values accounted for 23.70%，increased by 21.79%year -on -year，The production and sales rate is 96.06%。medium -sized enterprises account for 33.45%，increased by 14.93%year -on -year，The production and sales rate is 93.36%。Small enterprises account for 42.85%，increased by 29.12%year -on -year，The production and sales rate is 94.36%。Similar sales structure and output value of enterprises in various scale。
From January to November 2009, Shanghai Sinopastic Pharmaceutical Manufacturing Economy has accumulated industrial sales output value accounted for 72.17%of Shanghai's Chinese medicine industry 72.17%，decreased by 1.58%year -on -year，The production and sales rate is 100.16%。Foreign investment and Hong Kong, Macao and Taiwan investment account for 20.86%，increased by 25.31%year -on -year，The production and sales rate is 94.42%。State -owned economy accounts for 1.15%，decreased by 7.99%year -on -year，The production and sales rate is 101.96%。
Shanghai's major enterprises in China Pharmaceutical Manufacturing Industry Cumulative industrial sales output value accounts for 26.65%in Shanghai Zhongda Pharmaceutical Industry，decreased by 7.42%year -on -year，The production and sales rate is 108.39%。medium -sized enterprises account for 34.13%，increased by 18.09%year -on -year，The production and sales rate is 93.99%。Small enterprises account for 39.22%，increased by 3.35%year -on -year，The production and sales rate is 96.01%。
3.2 Main business income
From January to November 2009, the cumulative main business revenue of the National Pharmaceutical Manufacturing Industry was 169.896 billion yuan，Occupy the main business income of the pharmaceutical industry 20.18%，ranked 3rd among the eight major sub -industries，increased by 22.89%year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total of 4.086 billion yuan in main business income，occupying the main business income of Shanghai pharmaceutical industry 10.28%，5th in the eight major sub -industries in Shanghai's pharmaceutical industry，increased by 3.95%year -on -year。Shanghai's patent medicine manufacturing industry has achieved a total of main business My stake betting appStake Sports Bettingincome in the nation's patent pharmaceutical manufacturing region (19th place。
From January to November 2009, the cumulative market revenue of the national proprietary pharmaceutical manufacturing industry has accumulated main business income accounted for 58.57%，increased by 22.86%year -on -year。Followed by other economic types。Foreign capital, Hong Kong, Macao and Taiwan's investment economy cumulative main business income accounted for 15.88%，increased by 21.99%year -on -year。The state -owned economy accounts for 4.24%，increased by 6.75%year -on -year。The collective economy decreased by 5.71%year -on -year。
From January to November 2009, the large-scale enterprises in the country's Chinese medicine manufacturing industry have achieved the main business income account for 26.96%，increased by 21.57%year -on -year。medium -sized enterprises account for 32.23%，increased by 12.21%year -on -year。Small enterprises account for 40.81%，increased by 33.93%year -on -year。
From January to November 2009, Shanghai's proprietary Chinese medicine manufacturing industry stock system has achieved the main business income accounted for 82.28%of Shanghai's Chinese medicine industry 82.28%，increased by 0.18%year -on -year。Foreign investment and Hong Kong, Macao and Taiwan investment accounted for 13.56%，increased by 26.50%year -on -year。State -owned economy accounts for 0.66%，decreased by 10.10%year -on -year。
Shanghai's major enterprises in China Pharmaceutical Manufacturing Industry Cumulative Realization of the main business income accounted for 46.48%in Shanghai Zhongcheng Pharmaceutical Industry，decreased by 12.06%year -on -year。Middle -sized enterprises account for 23.19%，increased by 24.17%year -on -year。Small enterprises account for 30.33%，year -on -year increase of 22.93%。
3.3 Export delivery value
From January to November 2009, the cumulative export delivery value of the Chinese Pharmaceutical Manufacturing Industry National Pharmaceutical Manufacturing Industry was 4.144 billion yuan，accounting for 4.53%，ranked 6th among the eight major sub -industries in the pharmaceutical industry，increased by 15.75%year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total export delivery value of 214 million yuan，Occupable export value of Shanghai pharmaceutical industry 3.67%，No. 6 among the eight major sub -industries in Shanghai's pharmaceutical industry，increased by 1.69%year -on -year。Shanghai's patent medicine manufacturing industry from January to November 2009, the cumulative export delivery value ranked 6th in all regions of the country。
From January to November 2009, the cumulative export delivery value of the National Pharmaceutical Manufacturing Industry and the Hong Kong, Macao and Taiwan investment economy accounted for 47.85%，increased by 66.24%year -on -year。Second, the joint -stock economy accounts for 37.76%，decreased by 8.19%year -on -year。State -owned economy accounts for 10.74%，increased by 42.67%year -on -year。Other economic types decreased by 64.26%year -on -year。
From January to November 2009, the cumulative export delivery value of large-scale enterprises in China Pharmaceutical Manufacturing Industry accounted for 12.20%，increased by 6.54%year -on -year。Middle -sized enterprises account for 53.04%，increased by 11.29%year -on -year。Small enterprises account for 34.76%，increased by 27.40%year -on -year。
Shanghai's patent medicine manufacturing industry and Hong Kong, Macao and Taiwan investment economy cumulative export delivery value accounts for 89.63%of Shanghai's Chinese medicine industry 89.63%，increased by 9.62%year -on -year。The shareholding economy accounts for 10.37%，decreased by 37.44%year -on -year。State -owned economy、The collective economy and other economic types have no export delivery value。
From January to November 2009, large enterprises in Shanghai Zhongda Pharmaceutical Manufacturing Industry Cumulative export delivery value accounted for 3.69%of Shanghai Zhongda Pharmaceutical Industry，decreased by 12.35%year -on -year。Middle -sized enterprises account for 6.68%，decreased by 45.35%year -on -year。Small enterprises account for 89.63%，increased by 9.43%year -on -year。
4 Analysis of profit and profitability
4.1 Total profit
From January to November 2009, the cumulative total profit of the National Pharmaceutical Manufacturing Industry National Pharmaceutical Manufacturing Industry was 18.101 billion yuan，accounting for 20.94% in the national pharmaceutical industry，ranked 2nd among the eight major sub -industries in the pharmaceutical industry，increased by 25.44%year -on -year。
Shanghai's patent medicine manufacturing industry has achieved a total profit of 205 million yuan，accounting for the total profit of Shanghai's pharmaceutical industry 4.16%，5th in the eight major sub -industries in Shanghai's pharmaceutical industry，decreased by 1.91%year -on -year。Shanghai's patent medicine manufacturing industry ranked 20th in all regions of the country's Chinese medicine industry。
From January to November 2009, the cumulative profit of the national pharmaceutical manufacturing industry's stock system has accumulated total profit accounted for 59.71%，increased by 23.77%year -on -year。Foreign investment economy with foreign investment and Hong Kong, Macao and Taiwan accounted for 21.73%，increased by 21.68%year -on -year。The state -owned economy accounts for 4.01%，increased by 72.86%year -on -year。The collective economy decreased by 46.87%year -on -year。
From January to November 2009, the cumulative total profit of large-scale enterprises in China Pharmaceutical Manufacturing Industry accounted for 33.12%，increased by 17.93%year -on -year。Middle -sized enterprises account for 38.94%，increased by 20.03%year -on -year。Small enterprises account for 27.95%，increased by 45.57%year -on -year。
From January to November 2009, the cumulative profit of the shareholding economy in Shanghai China Pharmaceutical Manufacturing Industry has accumulated total My stake betting appprofits accounting for 68%，decreased by 13.96%year -on -year。stake betting appalso caused the overall decline in Shanghai's patent medicine manufacturing industry as a whole。Foreign investment economy in foreign investment, Hong Kong, Macao and Taiwan, a total of 29.35%，increased by 41.03%year -on -year。A total of the total profit of the state -owned economy loses a loss，Loss of 31 million yuan。
Local losses of large enterprises in Shanghai's pads medicine manufacturing industry，Loss of RMB 110 million，decreased by 123.90%year -on -year。directly affects the overall profit of Shanghai Zhongcheng Pharmaceutical Industry，Caused a decrease year -on -year。Middle -sized enterprises have achieved cumulative My stake betting appprofits accounting for 65.86%，increased by 46.83%year -on -year。Small enterprises account for 39.36%，increased by 11.75%year -on -year。
4.2 Cost cost profit margin
From January to November 2009, the cost and profit margin of the national pharmaceutical manufacturing industry is 12.04%，increased by 0.25 percentage points year -on -year。ranked 4th among the eight major sub -industries in the pharmaceutical industry。
The cost of profit margin in Shanghai's patent medicine manufacturing industry is 5.25%，No. 6 among the eight major sub -industries in Shanghai's pharmaceutical industry，decreased by 0.33 percentage points year -on -year。The cost rate of the cost and cost of Shanghai's patent medicine manufacturing industry is ranked 25th in the country's Chinese medicine industry area。
From January to November 2009, the cost rate of foreign investment in Chinese medicine manufacturing and Hong Kong, Macao and Taiwan investment economy is 17.17%，decreased by 0.04 percentage point year -on -year。Followed by the joint -stock economy，Cost cost profit margin is 12.18%，increased by 0.03 percentage points year -on -year。State -owned economic cost and cost profit margin is 11.18%，increased by 4.43 percentage points year -on -year。
From January to November 2009, the cost of large-scale enterprises in the national patent medicine manufacturing industry is 14.69%，decreased by 0.50 percentage point year -on -year。Middle -size enterprise cost and cost profit margin is 14.93%，increased by 0.96 percentage points year -on -year。Small enterprises are 8.11%，increased by 0.70 percentage points year -on -year。
The cost cost of the state -owned economy investment in the Chinese patent medicine manufacturing industry in Shanghai，The result obtained is the total profit of the total profit of the cumulative profit of January to November 2009。Foreign capital, Hong Kong, Macao and Taiwan's investment economy cost and expenditure profit margin is 12.17%，increased by 1.40 percentage points year -on -year。The shareholding economy is 4.30%，decreased by 0.75 percentage point year -on -year。
The cost cost of large -scale enterprises in Shanghai's major enterprises in China Pharmaceutical Manufacturing Industry，The result obtained was the total loss of total profit in January to November 2009。Middle -size enterprise cost and cost profit margin is 16.65%，increased by 2.87 percentage points year -on -year。Small enterprises are 6.97%，decreased by 0.73 percentage points year -on -year。
5 Summary
my country's Chinese Pharmaceutical Manufacturing Industry continues to maintain a good growth momentum from January to November 2009，Enterprises continue to increase，Leap the first place，This has advocated the development of Chinese medicine in recent years，There is a lot of connection to promoting the modernization of Chinese medicine。China Pharmaceutical Manufacturing Industry is still maintained in the three major pillar industries in my country's pharmaceutical industry。January to November 2009，Chinese adults are in production、Sales、profit and other indicators exceeded the original medicine industry of chemical drugs。But in terms of export，China Pharmaceutical Manufacturing Industry needs to take a long way，The development of Chinese medicine abroad can be said to be very successful，How to improve the exit of Chinese medicine，It will be the direction of the efforts of my country's Chinese medicine companies in the future。For Shanghai for the forefront of reform and opening up in my country，Cities that have attracted much attention from the foreign investment community，The development of Chinese patent medicine is not enough，Among the 8 sub -industries in Shanghai's pharmaceutical industry，The indicators of the Chinese medicine industry are arranged behind，Shanghai Chinese Yaoshi is even more backward in the country。Chinese medicine is the treasure of the Chinese nation，To develop modernization of Chinese medicine，Chinese medicine goes abroad，Shanghai has geographical advantages and international influence，If you have good policy support，Shanghai's proprietary patent medicine will be used later。
Shanghai Zhongda Pharmaceutical Industry is similar in terms of scale and economic structure，The size of the enterprise is still mainly small enterprises，But large enterprises are producing、Sales、profit rates such as profit and other indicators are high。Exit，Large enterprises are not as good as medium My stake betting app-sized enterprises and Stake Sports Bettingsmall enterprises。The investment in foreign investment in my country ’s medicine industry is growing，Chinese medicine companies invested in foreign investment and Hong Kong, Macao and Taiwan pay more attention to the export of Chinese patent medicines，From January to November 2009, the cumulative export delivery value was the most。Zhongcheng Pharmaceutical Enterprise is still mainly based on a joint -stock economy。
